Cardiac
CardiBloc 25 ER / 50 ER
Extended-release metoprolol succinate for steady 24-hour heart rate control.
“Consistent control. Stronger heart. Better outcomes.”
Composition
- Active ingredients
- Metoprolol Succinate Extended-Release
- Available strengths
- 25 mg, 50 mg
- Dosage form
- Extended-release tablets
- Pack size
- 10x3 tablets
Indications
- Hypertension
- Chronic Heart Failure
- Angina
- Arrhythmias
Dosage snapshot
- Starting dose
- 25 mg or 50 mg once daily
- Titration
- Increase gradually, under medical supervision
- Maximum dose
- 200 mg per day
Dosage should be individualised by the prescribing physician.
Key benefits
- Extended-release technology maintains steady plasma levels over 24 hours, avoiding peak-trough fluctuations.
- Consistent beta-1 selectivity for targeted cardiac action with minimal bronchial side effects.
- Once-daily dosing improves long-term compliance.
- Supports lower risk of mortality in heart failure and post-MI patients.
- Lower incidence of bradycardia and hypotension due to controlled release.
Why this formula works
CardiBloc's extended-release matrix releases metoprolol succinate gradually over 24 hours, replacing the sharp peaks and troughs seen with immediate-release beta-blockers with a smooth, sustained plasma profile.
This steadier exposure supports consistent beta-1 selective blockade around the clock, helping reduce cardiac workload while limiting the bronchial and haemodynamic side effects associated with fluctuating drug levels — an important consideration for patients on long-term therapy for hypertension, heart failure, angina, or arrhythmias.